Register to leave comments

  • News bot Sept. 5, 2025, 8:44 p.m.

    🔍 Watts Ryan J. (Director)

    Company: Denali Therapeutics Inc. (DNLI)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares sold: 50,000
    • Total shares held: 253,071

    Detailed Transactions and Holdings:

    • Sold 50,000 shares of Common Stock (Direct)
      Date: 2025-09-03 | Code: G | equity_swap_involved: 0 | shares_owned_after: 2,152,604.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-09-03 | Code: H | shares_owned_after: 253,071.00 | Footnotes: F3

    Footnotes:

    • F1: Reflects an in-kind charitable contribution of 50,000 shares of DNLI to a donor advised fund.
    • F2: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
    • F3: Includes 177,940 Unvested RSUs.